Research Topics
Species | Saik UrienSummaryCountry: France Publications
| Collaborators
|
Detail Information
Publications
Pharmacokinetics of epinephrine in patients with septic shock: modelization and interaction with endogenous neurohormonal statusImad Abboud
Medical Intensive Care Unit, Hopital Europeen Georges Pompidou, Assistance Publique Hopitaux de Paris, Universite Paris Descartes, Paris, France
Crit Care 13:R120. 2009..The purpose of this study was to investigate the pharmacokinetics of epinephrine and its determinants in patients with septic shock...
Developmental pharmacokinetics of etoposide in 67 children: lack of dexamethasone effectSaik Urien
CIC 0901 Inserm Necker Cochin and EA 3620, Paris, France
Cancer Chemother Pharmacol 67:597-603. 2011....
Lopinavir/ritonavir population pharmacokinetics in neonates and infantsSaik Urien
EA 3620, Universite Paris Descartes, Paris, France
Br J Clin Pharmacol 71:956-60. 2011..Lopinavir/ritonavir pharmacokinetics have been fully investigated in adults and children...
Pregnancy-related effects on lamivudine pharmacokinetics in a population study with 228 womenSihem Benaboud
Universite Paris Descartes, Paris, France
Antimicrob Agents Chemother 56:776-82. 2012..9. Pregnant women had a 22% higher apparent clearance than nonpregnant and parturient women; however, this increase did not lead to subexposure and should not require a dosage adjustment...
Is the recommended once-daily dose of lamivudine optimal in West African HIV-infected children?Naïm Bouazza
EA 3620, Universite Paris Descartes, Unite de recherche clinique, Hôpital Tarnier, 89 rue d Assas, 75006 Paris, France
Antimicrob Agents Chemother 54:3280-6. 2010..h was obtained with a 10-mg/kg once-daily lamivudine (3TC) dose for children below 17 kg; the recommended dose of 8 mg/kg seems to be sufficient in children weighing more than 17 kg. These assumptions should be prospectively confirmed...
Pregnancy-related effects on tenofovir pharmacokinetics: a population study with 186 womenSihem Benaboud
Université Paris Descartes Sorbonne Paris Cité, EA3620, Paris, France
Antimicrob Agents Chemother 56:857-62. 2012....
Population pharmacokinetics of atazanavir/ritonavir in HIV-1-infected children and adolescentsFrantz Foissac
EA 3620 Université Paris Descartes, Paris, France
Br J Clin Pharmacol 72:940-7. 2011..To investigate atazanavir (ATV) population pharmacokinetics in children and adolescents, establish factors that influence ATV pharmacokinetics and investigate the ATV exposure after recommended doses...
Pharmacokinetic modelling of the placental transfer of nelfinavir and its M8 metabolite: a population study using 75 maternal-cord plasma samplesDeborah Hirt
Pharmacologie Clinique, Assistance Publique Hopitaux de Paris, Groupe Hospitalier Cochin Saint Vincent De Paul, Faculté de Médecine René Descartes, Universite Paris 5, Paris, France
Br J Clin Pharmacol 64:634-44. 2007..A population pharmacokinetic model was developed to characterize the transfer of nelfinavir and its active metabolite M8 from maternal to cord plasma and amniotic fluid...
Population pharmacokinetics of tenofovir in HIV-1-infected pediatric patientsNaïm Bouazza
EA 3620, Universite Paris Descartes, Sorbonne Paris Cité France, Paris, France
J Acquir Immune Defic Syndr 58:283-8. 2011..The main goal was then to suggest for the first time the dose of tenofovir disoproxil fumarate (TDF) to give in children...
Is the recommended dose of efavirenz optimal in young West African human immunodeficiency virus-infected children?Deborah Hirt
EA3620, Universite Paris Descartes, Paris, France
Antimicrob Agents Chemother 53:4407-13. 2009..These assumptions should be prospectively confirmed...
Population pharmacokinetics of nevirapine in HIV-1-infected pregnant women and their neonatesSihem Benaboud
EA3620, Universite Paris Descartes, Paris, France
Antimicrob Agents Chemother 55:331-7. 2011..The neonate must receive sdNVP immediately after birth when the infant is born less than 30 min after maternal drug intake to keep NVP concentrations above the IC(50)...
Pharmacokinetics and virological efficacy after switch to once-daily lopinavir-ritonavir in treatment-experienced HIV-1-infected childrenFrantz Foissac
EA 3620 Université Paris Descartes, Paris, France
Antimicrob Agents Chemother 55:4320-5. 2011..The switch from the BID to the QD LPV/r regimen led to equivalent exposure and lower C(trough) values and resulted in lower levels of virological control in these antiretroviral-experienced children...
Developmental pharmacokinetics of lamivudine in 580 pediatric patients ranging from neonates to adolescentsNaïm Bouazza
EA 3620, Universite Paris Descartes, Paris, France
Antimicrob Agents Chemother 55:3498-504. 2011....
Pharmacokinetic-pharmacodynamic modeling of manganese after a single intravenous infusion of mangafodipir in patients with acute alcoholic hepatitisDeborah Hirt
EA3620, Universite Paris Descartes, Paris, France
Ther Drug Monit 31:557-65. 2009..2 days. Serum Mn concentrations could be related to a decrease in PT; the effect was longer in patients with an early decrease in total bilirubin serum concentrations...
Population pharmacokinetics of emtricitabine in human immunodeficiency virus type 1-infected pregnant women and their neonatesDeborah Hirt
EA3620, Universite Paris Descartes, Paris, France
Antimicrob Agents Chemother 53:1067-73. 2009..FTC was shown to have good placental transfer (80%). Administering 1 mg FTC/kg as soon as possible after birth or 2 mg/kg 12 h after birth should produce neonatal concentrations comparable to the concentrations observed in adults...
Pregnancy-related effects on nelfinavir-M8 pharmacokinetics: a population study with 133 womenDeborah Hirt
Pharmacologie Clinique, Hopital Saint Vincent de Paul, Paris, France
Antimicrob Agents Chemother 50:2079-86. 2006..The Bayesian individual pharmacokinetic estimates suggested that the dosage should not be changed in pregnant women but may be doubled on the day of delivery...
Didanosine population pharmacokinetics in West African human immunodeficiency virus-infected children administered once-daily tablets in relation to efficacy after one year of treatmentDeborah Hirt
EA3620, Universite Paris Descartes, Paris, France
Antimicrob Agents Chemother 53:4399-406. 2009..03) than that with a lower AUC. A didanosine dose of 360 mg/m2 administered as tablets should be a more appropriate dose than 240 mg/m2 to improve efficacy for these children. However, data on adverse events with this dosage are missing...
Population pharmacokinetics of tenofovir in human immunodeficiency virus-infected patients taking highly active antiretroviral therapyVincent Jullien
Service de Pharmacologie Clinique, Hopital Cochin Saint Vincent de Paul, 74 82 Avenue Denfert Rochereau, 75674 Paris Cedex 14, France
Antimicrob Agents Chemother 49:3361-6. 2005..In patients without tubular dysfunction, AUC(0-24) values markedly decreased from 6.7 to 1.4 mg . h/liter for BW/S(CR) increasing from 0.44 to 1.73. The relevance of a dosage adjustment based on BW/S(CR) should be further evaluated...
Population analysis of weight-, age-, and sex-related differences in the pharmacokinetics of lopinavir in children from birth to 18 yearsVincent Jullien
Service de Pharmacologie Clinique, Groupe Hospitalier Cochin Saint Vincent De Paul, 74 82 Avenue Denfert Rochereau, 75674 Paris Cedex 14, France
Antimicrob Agents Chemother 50:3548-55. 2006..The consequences of these pharmacokinetic discrepancies and the necessity to modify the currently recommended dosage regimen should be further investigated...
Dosing strategy in patients with renal failure receiving enoxaparin for the treatment of non-ST-segment elevation acute coronary syndromeJean Sebastien Hulot
Pharmacology Department, Institute of Cardiology, Pitie Salpetriere University Hospital, Paris, France
Clin Pharmacol Ther 77:542-52. 2005..However, little dosing information is available regarding the use of enoxaparin in patients with renal impairment...
Population pharmacokinetics of everolimus in cardiac recipients: comedications, ABCB1, and CYP3A5 polymorphismsFlorian Lemaître
Pharmacy Department, Pitie Salpetriere Hospital, Assistance Publique Hopitaux de Paris AP HP, Paris, France
Ther Drug Monit 34:686-94. 2012....
Population pharmacokinetics of clindamycin orally and intravenously administered in patients with osteomyelitisNaïm Bouazza
EA 3620, Universite Paris Descartes, Sorbonne Paris Cité, Paris, France
Br J Clin Pharmacol 74:971-7. 2012....
Population pharmacokinetics and pharmacodynamics of cysteamine in nephropathic cystinosis patientsNaïm Bouazza
EA 3620, Universite Paris Descartes, Sorbonne Paris Cité, France
Orphanet J Rare Dis 6:86. 2011..This study was aimed to describe the relationship between cysteamine plasma concentrations and white blood cell cystine levels, and to simulate an optimized administration scheme to improve the management of patients with cystinosis...
An optimized ibuprofen dosing scheme for preterm neonates with patent ductus arteriosus, based on a population pharmacokinetic and pharmacodynamic studyDeborah Hirt
EA3620, Universite Paris Descartes, Paris, France
Br J Clin Pharmacol 65:629-36. 2008..Few studies of ibuprofen pharmacokinetics have been performed and were limited to small groups of preterm infants, showing a large intersubject variability and an increase in clearance with either postnatal or gestational age...
Population pharmacokinetic study of methotrexate in patients with lymphoid malignancyDemiana William Faltaos
Pharmacology Department, Pitie Salpetriere University Hospital, Assistance Publique Hopitaux de Paris, Paris 6 University, Paris, France
Cancer Chemother Pharmacol 58:626-33. 2006..The final model was applied to the Bayesian estimation of MTX concentrations using two blood samples...
Tubular transporters and clearance of adefovirAude Servais
Nephrology Department, , , 75013, Paris, France
Eur J Pharmacol 540:168-74. 2006..Additional pharmacological inhibition of transporters decreased renal clearance, which may reflect inhibition of compensating transport mechanisms activated when MRP2 is lacking...
Effect of renal function on the pharmacokinetics of enoxaparin and consequences on dose adjustmentJean Sebastien Hulot
Pharmacology Department, Pitie Salpetriere University Hospital, Assistance Publique Hopitaux de Paris, Paris, France
Ther Drug Monit 26:305-10. 2004....
Population pharmacodynamic model of bicarbonate response to acetazolamide in mechanically ventilated chronic obstructive pulmonary disease patientsNicholas Heming
Medical Intensive Care Unit, European Georges Pompidou Hospital AP HP, Universite Paris Descartes, Sorbonne Paris Cité, 20 rue Leblanc, 75908 Paris, France
Crit Care 15:R213. 2011..Little is known of the pharmacodynamics of acetazolamide in the critically ill. We undertook the pharmacodynamic modeling of bicarbonate response to acetazolamide in COPD patients under mechanical ventilation...
Oxaliplatin plus irinotecan and FU-FOL combination and pharmacokinetic analysis in advanced colorectal cancer patientsMarian A Gil-Delgado
SOMPS, Salpetriere Hospital, Paris, France
Am J Clin Oncol 27:294-8. 2004..It would appear that the dose and schedule defined by this trial could be proposed as front-line therapy for advanced colorectal carcinoma to establish rapid disease control and to permit patients to proceed to surgery...
Intravenous morphine titration in immediate postoperative pain management: population kinetic-pharmacodynamic and logistic regression analysisHala Abou Hammoud
Pharmacology Department, Pitie Salpetriere Hospital, Assistance Publique Hopitaux de Paris, Universite Pierre et Marie Curie Paris 6, Paris, France
Pain 144:139-46. 2009..Our study supported the possibility of modeling the time course of a complex response in the absence of pharmacokinetic data. The current data should lead to a more rational management of the immediate postoperative pain...
Prediction tacrolimus blood levels based on the Bayesian method in adult kidney transplant patientsMarie Antignac
Pharmacy Department, Pitié Salpêtrière Hospital AP HP, 47 bd de l Hopital, 75013, Paris, France
Eur J Drug Metab Pharmacokinet 36:25-33. 2011..28 ± 0.58 ng/ml). The present study demonstrates the suitability of the Bayesian method for the prediction of trough blood concentrations of tacrolimus using only few samples in adult kidney transplantation recipients...
[Tubular transporters OAT1 and MRP2 and clearance of adefovir]Aude Servais
Service de Nephrologie, CHU Pitie Salpetriere, Paris, France
Nephrol Ther 1:296-300. 2005..Additional pharmacological inhibition of transporters decreased renal clearance, which may reflect inhibition of compensating transport mechanisms activated when MRP2 is lacking...
Population pharmacokinetics of tacrolimus in full liver transplant patients: modelling of the post-operative clearanceMarie Antignac
Department of Pharmacy, Pitie Salpetriere Hospital, 47 bd de l Hopital, 75013, Paris, France
Eur J Clin Pharmacol 61:409-16. 2005..To investigate the population pharmacokinetics of tacrolimus in an adult liver transplant cohort using routine drug monitoring data and to identify patient characteristics that influence pharmacokinetic parameters...
